The AURORA initiative for metastatic breast cancer.

导出 OA

翻译打印收藏纠错

第一作者： D,Zardavas

第一单位： 1] Breast International Group Headquarters (BIG-aisbl), Brussels, Belgium [2] Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium.

作者： D,Zardavas ^[1] ; M,Maetens ^[2] ; A,Irrthum ^[3] ; T,Goulioti ^[3] ; K,Engelen ^[3] ; D,Fumagalli ^[2] ; R,Salgado ^[3] ; P,Aftimos ^[4] ; K S,Saini ^[3] ; C,Sotiriou ^[5] ; P,Campbell ^[6] ; P,Dinh ^[7] ; G,von Minckwitz ^[8] ; R D,Gelber ^[8] ; M,Dowsett ^[8] ; A,Di Leo ^[8] ; D,Cameron ^[8] ; J,Baselga ^[8] ; M,Gnant ^[8] ; A,Goldhirsch ^[8] ; L,Norton ^[9] ; M,Piccart ^[10]

作者单位： 1] Breast International Group Headquarters (BIG-aisbl), Brussels, Belgium [2] Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. ^[1] 1] Breast International Group Headquarters (BIG-aisbl), Brussels, Belgium [2] Breast Cancer Translational Research Laboratory - J.C. Heuson, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. ^[2] Breast International Group Headquarters (BIG-aisbl), Brussels, Belgium. ^[3] Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. ^[4] Breast Cancer Translational Research Laboratory - J.C. Heuson, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. ^[5] Cancer Genome Project, Wellcome Trust Sanger Institute, Hinxton, UK. ^[6] Medical Oncology, Nepean Hospital, Penrith, NSW, Australia. ^[7] Breast International Group Executive Board. ^[8] Breast Cancer Medicine Service, Memorial Sloan-Kettering Cancer Center, New York, NY, USA. ^[9] 1] Breast International Group Headquarters (BIG-aisbl), Brussels, Belgium [2] Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium [3] Breast International Group Executive Board. ^[10]